Condition: Cancer · Childhood Cancer · Chemotherapy-induced Peripheral Neuropathy · Sponsor: Yale University
The purpose of this study is to determine feasibility and acceptability of a six-week at-home light therapy protocol in childhood cancer survivors, to identify facilitators and barriers to implementing this intervention, and to measure signs and symptoms of Chemotherapy Induced Peripheral Neuropathy (CIPN) at baseline and following completion of the at-home light therapy protocol.
This description comes directly from the study's public registry record.
Rozalyn Rodwin, MD · 203-785-2407 · rozalyn.rodwin@yale.edu
Jaime Rotatori, BSN, MS · 203-785-2407 · jaime.rotatori@yale.edu
Always discuss trial participation with your own doctor first.
| Yale New Haven Health Smilow York Street Hospital | New Haven, Connecticut, United States | Recruiting |
| Yale New Haven Health Park Avenue Medical Center | Trumbull, Connecticut, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07019259